Literature DB >> 10467910

Efficacy of spinal cord stimulation for neuropathic pain following idiopathic acute transverse myelitis: a case report.

J G Laffey1, D Murphy, J Regan, D O'Keeffe.   

Abstract

Spinal cord stimulation (SCS) involves the electrical stimulation of dorsal structures within the spinal cord, and is the most widespread application of neurostimulation for the relief of chronic pain. Idiopathic acute transverse myelitis (IATM) is an acute monophasic lesion of the spinal cord that presents with symptoms associated with loss of cord function. The incidence of chronic pain secondary to this condition is unknown, but is considered rare. We report the efficacy of SCS for relief of severe neuropathic pain in both lower limbs secondary to IATM, which had failed to respond to conventional pain therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10467910     DOI: 10.1016/s0303-8467(99)00012-8

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  High-level cervical spinal cord stimulation used to treat intractable pain arising from transverse myelitis caused by schistosomiasis.

Authors:  Jin Kyung Kim; Seok Ho Hong; Jung-Kyo Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-02-28

2.  Relief of Neuropathic Pain After Spinal Cord Stimulator Implantation in a Patient With Idiopathic Thoracic Transverse Myelitis: A Case Report.

Authors:  Rajiv Reddy; Rupa Prasad; Sepehr Rejai; Kenneth Halter; Jeffrey Chen
Journal:  A A Pract       Date:  2019-12-01

3.  Intrathecal drug delivery to treat intractable neuropathic pain following Sjögren's syndrome-induced transverse myelitis: A case report.

Authors:  Ji Yeong Kim; Yong Ho Lee; Ji Young Kim; Hyun Hwa Lee; Young Hoon Kim
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

4.  Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.

Authors:  Wei-Ting Wu; Yu-Hui Huang; Der-Cherng Chen; Yu-Hsuan Huang; Li-Wei Chou
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-29       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.